GSK confirms start date for Luke Miels

RNS Number : 5167I

GlaxoSmithKline PLC

19 June 2017

 

Issued: Monday 19 June 2017, London UK - LSE

GSK confirms start date for Luke Miels

GSK has reached an agreement with AstraZeneca that Luke Miels will commence his appointment as President, Global Pharmaceuticals, GSK on 4 September 2017.  

GSK enquiries:
UK Media enquiries:	Simon Steel	[phone]	(London)
	David Mawdsley	[phone]	(London)
US Media enquiries:	Sarah Alspach	[phone]	(Washington, DC)
	Sarah Spencer	[phone]	(Philadelphia)
Analyst/Investor enquiries:	Sarah Elton-Farr	[phone]	(London)
	Tom Curry	+ 1 215 751 5419	(Philadelphia)
	Gary Davies	[phone]	(London)
	James Dodwell	[phone]	(London)
	Jeff McLaughlin	[phone]	(Philadelphia)

GSK cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Principal risks and uncertainties' in the company's Annual Report on Form 20-F for 2016.
Registered in England & Wales: No. 3888792
Registered Office: 980 Great West Road Brentford, Middlesex TW8 9GS

 

END

 

 

MSCZMGMVKLNGNZM